Result
Sep 9, 2024 → Jul 27, 2026 · 1y 10mo
Today's value
$1,633.46+63.35%
Initial investment
$1,000
Profit
$633.46
Annual return (CAGR)
+29.83%
Historical return extremes for Climb Bio (CLYM) from 2024 to 2026
What if you bought at the best or worst time? Max profit, max drawdown, and total return since IPO.
| Scenario | Return | Start date | Start price | End date | End price | $1,000 becomes |
|---|---|---|---|---|---|---|
| Max profitMore info about Max profit | +1,139% | $1.13 | $14 | $12,389.38 | ||
| Max drawdownMore info about Max drawdown | -86.64% | $8.46 | $1.13 | $133.57 | ||
| Return since IPOMore info about Return since IPO | +63.35% | $7.83 | $12.79 | $1,633.46 |
- Max profitMore info about Max profit+1,139%$12,389.38
- Max drawdownMore info about Max drawdown-86.64%$133.57
- Return since IPOMore info about Return since IPO+63.35%$1,633.46
Each row shows the start and end dates and prices for the scenario, the period return, and the resulting outcome for a $1,000 investment in Climb Bio (CLYM). Max profit is the best buy-and-sell pair across the entire price history; max drawdown is the worst peak-to-trough decline; the last row tracks return from IPO to today. Prices are split- and dividend-adjusted closing prices — actual outcomes would differ due to fees, taxes, and slippage.
Frequently asked questions
Data & methodology
Climb Bio (CLYM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.